Drug information for CEFACLOR

Form Dosage Status Therapeutic Equivalence Active Ingred Ref. Sponsor Document
CAPSULE; ORAL EQ 250MG BASE Discontinued   CEFACLOR Cefaclor CEPH INTL 62205
CAPSULE; ORAL EQ 500MG BASE Discontinued   CEFACLOR Cefaclor CEPH INTL   "
CAPSULE; ORAL EQ 250MG BASE Discontinued   CEFACLOR Cefaclor IVAX SUB TEVA PHARMS 64061
CAPSULE; ORAL EQ 500MG BASE Discontinued   CEFACLOR Cefaclor IVAX SUB TEVA PHARMS   "
CAPSULE; ORAL EQ 250MG BASE Discontinued   CEFACLOR Cefaclor TEVA 64081
1998-09-16 Letter
1998-09-16 Label
1998-09-16 Review
CAPSULE; ORAL EQ 500MG BASE Discontinued   CEFACLOR Cefaclor TEVA   "
CAPSULE; ORAL EQ 250MG BASE Discontinued   CEFACLOR Cefaclor CLONMEL HLTHCARE 64107
CAPSULE; ORAL EQ 500MG BASE Discontinued   CEFACLOR Cefaclor CLONMEL HLTHCARE   "
CAPSULE; ORAL EQ 250MG BASE Discontinued   CEFACLOR Cefaclor TEVA 64145
CAPSULE; ORAL EQ 500MG BASE Discontinued   CEFACLOR Cefaclor TEVA   "
CAPSULE; ORAL EQ 250MG BASE Discontinued   CEFACLOR Cefaclor MARSAM PHARMS LLC 64148
CAPSULE; ORAL EQ 500MG BASE Discontinued   CEFACLOR Cefaclor MARSAM PHARMS LLC   "
CAPSULE; ORAL EQ 250MG BASE Prescription AB  CEFACLOR Cefaclor RANBAXY 64156
CAPSULE; ORAL EQ 500MG BASE Prescription AB  CEFACLOR Cefaclor RANBAXY   "
CAPSULE; ORAL EQ 250MG BASE Prescription AB  CEFACLOR Cefaclor YUNG SHIN PHARM 65146
CAPSULE; ORAL EQ 500MG BASE Prescription AB  CEFACLOR Cefaclor YUNG SHIN PHARM   "
CAPSULE; ORAL EQ 250MG BASE Prescription AB  CEFACLOR Cefaclor HIKMA 65350
CAPSULE; ORAL EQ 500MG BASE Prescription AB (Reference Drug) CEFACLOR Cefaclor HIKMA   "
FOR SUSPENSION; ORAL EQ 125MG BASE/5ML Discontinued   CEFACLOR Cefaclor FACTA FARMA 62206
FOR SUSPENSION; ORAL EQ 187MG BASE/5ML Discontinued   CEFACLOR Cefaclor FACTA FARMA   "
FOR SUSPENSION; ORAL EQ 250MG BASE/5ML Discontinued   CEFACLOR Cefaclor FACTA FARMA   "
FOR SUSPENSION; ORAL EQ 375MG BASE/5ML Discontinued   CEFACLOR Cefaclor FACTA FARMA   "
FOR SUSPENSION; ORAL EQ 375MG BASE/5ML Discontinued   CEFACLOR Cefaclor IVAX SUB TEVA PHARMS 64070
FOR SUSPENSION; ORAL EQ 250MG BASE/5ML Discontinued   CEFACLOR Cefaclor IVAX SUB TEVA PHARMS 64085
FOR SUSPENSION; ORAL EQ 187MG BASE/5ML Discontinued   CEFACLOR Cefaclor IVAX SUB TEVA PHARMS 64086
FOR SUSPENSION; ORAL EQ 125MG BASE/5ML Discontinued   CEFACLOR Cefaclor IVAX SUB TEVA PHARMS 64087
FOR SUSPENSION; ORAL EQ 375MG BASE/5ML Discontinued   CEFACLOR Cefaclor CLONMEL HLTHCARE 64110
FOR SUSPENSION; ORAL EQ 125MG BASE/5ML Discontinued   CEFACLOR Cefaclor CLONMEL HLTHCARE 64114
FOR SUSPENSION; ORAL EQ 187MG BASE/5ML Discontinued   CEFACLOR Cefaclor CLONMEL HLTHCARE 64115
FOR SUSPENSION; ORAL EQ 250MG BASE/5ML Discontinued   CEFACLOR Cefaclor CLONMEL HLTHCARE 64116
FOR SUSPENSION; ORAL EQ 375MG BASE/5ML Prescription AB (Reference Drug) CEFACLOR Cefaclor RANBAXY 64155
2003-07-31 Review
FOR SUSPENSION; ORAL EQ 250MG BASE/5ML Prescription AB (Reference Drug) CEFACLOR Cefaclor RANBAXY 64164
2003-07-31 Review
FOR SUSPENSION; ORAL EQ 187MG BASE/5ML Prescription AB (Reference Drug) CEFACLOR Cefaclor RANBAXY 64165
2003-07-31 Review
FOR SUSPENSION; ORAL EQ 125MG BASE/5ML Prescription AB (Reference Drug) CEFACLOR Cefaclor RANBAXY 64166
2003-07-31 Review
FOR SUSPENSION; ORAL EQ 125MG BASE/5ML Discontinued   CEFACLOR Cefaclor MARSAM PHARMS LLC 64204
1998-02-16 Review
FOR SUSPENSION; ORAL EQ 187MG BASE/5ML Discontinued   CEFACLOR Cefaclor MARSAM PHARMS LLC 64205
1998-02-16 Review
FOR SUSPENSION; ORAL EQ 250MG BASE/5ML Discontinued   CEFACLOR Cefaclor MARSAM PHARMS LLC 64206
1998-02-16 Review
FOR SUSPENSION; ORAL EQ 375MG BASE/5ML Discontinued   CEFACLOR Cefaclor MARSAM PHARMS LLC 64207
1998-02-16 Review
FOR SUSPENSION; ORAL EQ 125MG BASE/5ML Prescription AB  CEFACLOR Cefaclor YUNG SHIN PHARM 65412
FOR SUSPENSION; ORAL EQ 187MG BASE/5ML Prescription AB  CEFACLOR Cefaclor YUNG SHIN PHARM   "
FOR SUSPENSION; ORAL EQ 250MG BASE/5ML Prescription AB  CEFACLOR Cefaclor YUNG SHIN PHARM   "
FOR SUSPENSION; ORAL EQ 375MG BASE/5ML Prescription AB  CEFACLOR Cefaclor YUNG SHIN PHARM   "
TABLET, EXTENDED RELEASE; ORAL EQ 500MG BASE Discontinued   CEFACLOR Cefaclor WORLD GEN 65057
TABLET, EXTENDED RELEASE; ORAL EQ 375MG BASE Prescription   CEFACLOR Cefaclor TEVA 65058
TABLET, EXTENDED RELEASE; ORAL EQ 500MG BASE Prescription  (Reference Drug) CEFACLOR Cefaclor TEVA   "

Drug Adverse Effects information for CEFACLOR

Role code Indications Reaction # Reports
PS PRODUCT USED FOR UNKNOWN INDICATION ANAPHYLACTIC SHOCK 7
SS ANTIPYRESIS ASPARTATE AMINOTRANSFERASE INCREASED 4
SS ANTIPYRESIS BLOOD CREATINE PHOSPHOKINASE DECREASED 4
SS ANTIPYRESIS C-REACTIVE PROTEIN INCREASED 4
SS ANTIPYRESIS GAMMA-GLUTAMYLTRANSFERASE INCREASED 4
SS ANTIPYRESIS GRANULOCYTOPENIA 4
SS ANTIPYRESIS INFLAMMATION 4
SS ANTIPYRESIS WHITE BLOOD CELL COUNT INCREASED 4
SS BACTERIAL INFECTION ASPARTATE AMINOTRANSFERASE INCREASED 6
SS BACTERIAL INFECTION BLOOD CREATINE PHOSPHOKINASE DECREASED 6
SS BACTERIAL INFECTION C-REACTIVE PROTEIN INCREASED 6
SS BACTERIAL INFECTION GAMMA-GLUTAMYLTRANSFERASE INCREASED 6
SS BACTERIAL INFECTION GRANULOCYTOPENIA 6
SS BACTERIAL INFECTION INFLAMMATION 6
SS BACTERIAL INFECTION WHITE BLOOD CELL COUNT INCREASED 6
SS CONSTIPATION ASPARTATE AMINOTRANSFERASE INCREASED 2
SS CONSTIPATION BLOOD CREATINE PHOSPHOKINASE DECREASED 2
SS CONSTIPATION C-REACTIVE PROTEIN INCREASED 2
SS CONSTIPATION GAMMA-GLUTAMYLTRANSFERASE INCREASED 2
SS CONSTIPATION GRANULOCYTOPENIA 2
SS CONSTIPATION INFLAMMATION 2
SS CONSTIPATION WHITE BLOOD CELL COUNT INCREASED 2
SS GASTRITIS HEPATITIS FULMINANT 2
SS PAIN ASPARTATE AMINOTRANSFERASE INCREASED 2
SS PAIN BLOOD CREATINE PHOSPHOKINASE DECREASED 2
SS PAIN C-REACTIVE PROTEIN INCREASED 2
SS PAIN GAMMA-GLUTAMYLTRANSFERASE INCREASED 2
SS PAIN GRANULOCYTOPENIA 2
SS PAIN INFLAMMATION 2
SS PAIN WHITE BLOOD CELL COUNT INCREASED 2
SS PROPHYLAXIS ASPARTATE AMINOTRANSFERASE INCREASED 2
SS PROPHYLAXIS BLOOD CREATINE PHOSPHOKINASE DECREASED 2
SS PROPHYLAXIS C-REACTIVE PROTEIN INCREASED 2
SS PROPHYLAXIS GAMMA-GLUTAMYLTRANSFERASE INCREASED 2
SS PROPHYLAXIS GRANULOCYTOPENIA 2
SS PROPHYLAXIS INFLAMMATION 2
SS PROPHYLAXIS WHITE BLOOD CELL COUNT INCREASED 2
SS PROPHYLAXIS OF NAUSEA AND VOMITING ASPARTATE AMINOTRANSFERASE INCREASED 2
SS PROPHYLAXIS OF NAUSEA AND VOMITING BLOOD CREATINE PHOSPHOKINASE DECREASED 2
SS PROPHYLAXIS OF NAUSEA AND VOMITING C-REACTIVE PROTEIN INCREASED 2
SS PROPHYLAXIS OF NAUSEA AND VOMITING GAMMA-GLUTAMYLTRANSFERASE INCREASED 2
SS PROPHYLAXIS OF NAUSEA AND VOMITING GRANULOCYTOPENIA 2
SS PROPHYLAXIS OF NAUSEA AND VOMITING INFLAMMATION 2
SS PROPHYLAXIS OF NAUSEA AND VOMITING WHITE BLOOD CELL COUNT INCREASED 2
SS PYREXIA HEPATIC ENCEPHALOPATHY 1
SS PYREXIA HEPATITIS FULMINANT 7
SS PYREXIA PYREXIA 1
SS TONSILLITIS DIARRHOEA 2
SS TONSILLITIS GASTROENTERITIS ROTAVIRUS 2
SS TONSILLITIS NOSOCOMIAL INFECTION 2
SS TONSILLITIS PYREXIA 2
SS TONSILLITIS VOMITING 2
SS TOOTH EXTRACTION HEPATIC ENCEPHALOPATHY 1
SS TOOTH EXTRACTION HEPATITIS FULMINANT 1
SS TOOTH EXTRACTION PYREXIA 1
C BACK PAIN UVEITIS 6
C BONE DENSITY ABNORMAL UVEITIS 3
C BONE DENSITY DECREASED UVEITIS 3
C CHRONIC MYELOID LEUKAEMIA BASOPHIL COUNT INCREASED 2
C CHRONIC MYELOID LEUKAEMIA BLOOD ALKALINE PHOSPHATASE INCREASED 2
C CHRONIC MYELOID LEUKAEMIA BLOOD CREATININE INCREASED 2
C CHRONIC MYELOID LEUKAEMIA BLOOD LACTATE DEHYDROGENASE INCREASED 2
C CHRONIC MYELOID LEUKAEMIA BLOOD UREA INCREASED 2
C CHRONIC MYELOID LEUKAEMIA CONSTIPATION 2
C CHRONIC MYELOID LEUKAEMIA DYSPHONIA 2
C CHRONIC MYELOID LEUKAEMIA GAMMA-GLUTAMYLTRANSFERASE INCREASED 2
C CHRONIC MYELOID LEUKAEMIA HEPATIC FUNCTION ABNORMAL 2
C CHRONIC MYELOID LEUKAEMIA HYPERGLYCAEMIA 2
C CHRONIC MYELOID LEUKAEMIA MALAISE 2
C CHRONIC MYELOID LEUKAEMIA NEOPLASM MALIGNANT 2
C CHRONIC MYELOID LEUKAEMIA NEOPLASM PROGRESSION 2
C CHRONIC MYELOID LEUKAEMIA PALPITATIONS 2
C CHRONIC MYELOID LEUKAEMIA PHOTOPHOBIA 2
C CHRONIC MYELOID LEUKAEMIA WEIGHT DECREASED 2
C CHRONIC MYELOID LEUKAEMIA WHITE BLOOD CELL COUNT INCREASED 2
C CORONARY ARTERY DISEASE UVEITIS 3
C DIABETIC GASTROPARESIS ACTIVITIES OF DAILY LIVING IMPAIRED 1
C DIABETIC GASTROPARESIS ANXIETY 1
C DIABETIC GASTROPARESIS AREFLEXIA 1
C DIABETIC GASTROPARESIS ARTHRALGIA 1
C DIABETIC GASTROPARESIS ARTHRITIS 1
C DIABETIC GASTROPARESIS ASTHENIA 1
C DIABETIC GASTROPARESIS BALANCE DISORDER 1
C DIABETIC GASTROPARESIS CHOKING 1
C DIABETIC GASTROPARESIS CONTUSION 1
C DIABETIC GASTROPARESIS COUGH 1
C DIABETIC GASTROPARESIS DECUBITUS ULCER 1
C DIABETIC GASTROPARESIS DEFORMITY 1
C DIABETIC GASTROPARESIS DEPRESSION 1
C DIABETIC GASTROPARESIS DIABETIC NEUROPATHY 1
C DIABETIC GASTROPARESIS DIZZINESS 1
C DIABETIC GASTROPARESIS DRY MOUTH 1
C DIABETIC GASTROPARESIS DUODENITIS 1
C DIABETIC GASTROPARESIS DYSARTHRIA 1
C DIABETIC GASTROPARESIS DYSPEPSIA 1
C DIABETIC GASTROPARESIS DYSPHAGIA 1
C DIABETIC GASTROPARESIS DYSPNOEA 1
C DIABETIC GASTROPARESIS DYSTONIA 1
C DIABETIC GASTROPARESIS EARLY SATIETY 1
C DIABETIC GASTROPARESIS EXTRAPYRAMIDAL DISORDER 1
C DIABETIC GASTROPARESIS FALL 1
C DIABETIC GASTROPARESIS FATIGUE 1
C DIABETIC GASTROPARESIS FUNGAL INFECTION 1
C DIABETIC GASTROPARESIS GASTRIC DISORDER 1
C DIABETIC GASTROPARESIS GASTRITIS 1
C DIABETIC GASTROPARESIS GASTROOESOPHAGEAL REFLUX DISEASE 1
C DIABETIC GASTROPARESIS GLOSSODYNIA 1
C DIABETIC GASTROPARESIS HYPERLIPIDAEMIA 1
C DIABETIC GASTROPARESIS HYPOGLYCAEMIA 1
C DIABETIC GASTROPARESIS HYPOKALAEMIA 1
C DIABETIC GASTROPARESIS HYPOMAGNESAEMIA 1
C DIABETIC GASTROPARESIS JOINT SWELLING 1
C DIABETIC GASTROPARESIS LEUKOCYTOSIS 1
C DIABETIC GASTROPARESIS MENTAL DISORDER 1
C DIABETIC GASTROPARESIS MENTAL STATUS CHANGES 1
C DIABETIC GASTROPARESIS MULTIPLE INJURIES 1
C DIABETIC GASTROPARESIS MUSCULAR WEAKNESS 1
C DIABETIC GASTROPARESIS NAUSEA 1
C DIABETIC GASTROPARESIS NERVOUS SYSTEM DISORDER 1
C DIABETIC GASTROPARESIS OBESITY 1
C DIABETIC GASTROPARESIS PAIN 1
C DIABETIC GASTROPARESIS PHARYNGITIS 1
C DIABETIC GASTROPARESIS PLEURISY 1
C DIABETIC GASTROPARESIS RESPIRATORY TRACT CONGESTION 1
C DIABETIC GASTROPARESIS RIB FRACTURE 1
C DIABETIC GASTROPARESIS SINUSITIS 1
C DIABETIC GASTROPARESIS SLEEP DISORDER 1
C DIABETIC GASTROPARESIS SPEECH DISORDER 1
C DIABETIC GASTROPARESIS TARDIVE DYSKINESIA 1
C DIABETIC GASTROPARESIS TONGUE DISORDER 1
C DIABETIC GASTROPARESIS TREATMENT NONCOMPLIANCE 1
C DIABETIC GASTROPARESIS UPPER RESPIRATORY TRACT INFECTION 1
C DIABETIC GASTROPARESIS URINARY TRACT INFECTION 1
C DIABETIC GASTROPARESIS VERTIGO 1
C DIABETIC GASTROPARESIS VOMITING 1
C DYSURIA HYPERSENSITIVITY 1
C DYSURIA INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 1
C GASTROOESOPHAGEAL REFLUX DISEASE ACTIVITIES OF DAILY LIVING IMPAIRED 1
C GASTROOESOPHAGEAL REFLUX DISEASE ANXIETY 1
C GASTROOESOPHAGEAL REFLUX DISEASE AREFLEXIA 1
C GASTROOESOPHAGEAL REFLUX DISEASE ARTHRALGIA 1
C GASTROOESOPHAGEAL REFLUX DISEASE ARTHRITIS 1
C GASTROOESOPHAGEAL REFLUX DISEASE ASTHENIA 1
C GASTROOESOPHAGEAL REFLUX DISEASE BALANCE DISORDER 1
C GASTROOESOPHAGEAL REFLUX DISEASE CHOKING 1
C GASTROOESOPHAGEAL REFLUX DISEASE CONTUSION 1
C GASTROOESOPHAGEAL REFLUX DISEASE COUGH 1
C GASTROOESOPHAGEAL REFLUX DISEASE DECUBITUS ULCER 1
C GASTROOESOPHAGEAL REFLUX DISEASE DEFORMITY 1
C GASTROOESOPHAGEAL REFLUX DISEASE DEPRESSION 1
C GASTROOESOPHAGEAL REFLUX DISEASE DIABETIC NEUROPATHY 1
C GASTROOESOPHAGEAL REFLUX DISEASE DIZZINESS 1
C GASTROOESOPHAGEAL REFLUX DISEASE DRY MOUTH 1
C GASTROOESOPHAGEAL REFLUX DISEASE DUODENITIS 1
C GASTROOESOPHAGEAL REFLUX DISEASE DYSARTHRIA 1
C GASTROOESOPHAGEAL REFLUX DISEASE DYSPEPSIA 1
C GASTROOESOPHAGEAL REFLUX DISEASE DYSPHAGIA 1
C GASTROOESOPHAGEAL REFLUX DISEASE DYSPNOEA 1
C GASTROOESOPHAGEAL REFLUX DISEASE DYSTONIA 1
C GASTROOESOPHAGEAL REFLUX DISEASE EARLY SATIETY 1
C GASTROOESOPHAGEAL REFLUX DISEASE EXTRAPYRAMIDAL DISORDER 1
C GASTROOESOPHAGEAL REFLUX DISEASE FALL 1
C GASTROOESOPHAGEAL REFLUX DISEASE FATIGUE 1
C GASTROOESOPHAGEAL REFLUX DISEASE FUNGAL INFECTION 1
C GASTROOESOPHAGEAL REFLUX DISEASE GASTRIC DISORDER 1
C GASTROOESOPHAGEAL REFLUX DISEASE GASTRITIS 1
C GASTROOESOPHAGEAL REFLUX DISEASE GASTROOESOPHAGEAL REFLUX DISEASE 1
C GASTROOESOPHAGEAL REFLUX DISEASE GLOSSODYNIA 1
C GASTROOESOPHAGEAL REFLUX DISEASE HYPERLIPIDAEMIA 1
C GASTROOESOPHAGEAL REFLUX DISEASE HYPOGLYCAEMIA 1
C GASTROOESOPHAGEAL REFLUX DISEASE HYPOKALAEMIA 1
C GASTROOESOPHAGEAL REFLUX DISEASE HYPOMAGNESAEMIA 1
C GASTROOESOPHAGEAL REFLUX DISEASE JOINT SWELLING 1
C GASTROOESOPHAGEAL REFLUX DISEASE LEUKOCYTOSIS 1
C GASTROOESOPHAGEAL REFLUX DISEASE MENTAL DISORDER 1
C GASTROOESOPHAGEAL REFLUX DISEASE MENTAL STATUS CHANGES 1
C GASTROOESOPHAGEAL REFLUX DISEASE MULTIPLE INJURIES 1
C GASTROOESOPHAGEAL REFLUX DISEASE MUSCULAR WEAKNESS 1
C GASTROOESOPHAGEAL REFLUX DISEASE NAUSEA 1
C GASTROOESOPHAGEAL REFLUX DISEASE NERVOUS SYSTEM DISORDER 1
C GASTROOESOPHAGEAL REFLUX DISEASE OBESITY 1
C GASTROOESOPHAGEAL REFLUX DISEASE PAIN 1
C GASTROOESOPHAGEAL REFLUX DISEASE PHARYNGITIS 1
C GASTROOESOPHAGEAL REFLUX DISEASE PLEURISY 1
C GASTROOESOPHAGEAL REFLUX DISEASE RESPIRATORY TRACT CONGESTION 1
C GASTROOESOPHAGEAL REFLUX DISEASE RIB FRACTURE 1
C GASTROOESOPHAGEAL REFLUX DISEASE SINUSITIS 1
C GASTROOESOPHAGEAL REFLUX DISEASE SLEEP DISORDER 1
C GASTROOESOPHAGEAL REFLUX DISEASE SPEECH DISORDER 1
C GASTROOESOPHAGEAL REFLUX DISEASE TARDIVE DYSKINESIA 1
C GASTROOESOPHAGEAL REFLUX DISEASE TONGUE DISORDER 1
C GASTROOESOPHAGEAL REFLUX DISEASE TREATMENT NONCOMPLIANCE 1
C GASTROOESOPHAGEAL REFLUX DISEASE UPPER RESPIRATORY TRACT INFECTION 1
C GASTROOESOPHAGEAL REFLUX DISEASE URINARY TRACT INFECTION 1
C GASTROOESOPHAGEAL REFLUX DISEASE VERTIGO 1
C GASTROOESOPHAGEAL REFLUX DISEASE VOMITING 1
C HYPERLIPIDAEMIA UVEITIS 3
C HYPERTENSION UVEITIS 6
C LOWER RESPIRATORY TRACT INFECTION UVEITIS 3
C MENIERE'S DISEASE UVEITIS 3
C PANCREATIC CARCINOMA BILIARY TRACT INFECTION 2
C PANCREATIC CARCINOMA DECREASED APPETITE 2
C PANCREATIC CARCINOMA DISEASE PROGRESSION 2
C PANCREATIC CARCINOMA FATIGUE 2
C PANCREATIC CARCINOMA WHITE BLOOD CELL COUNT DECREASED 2
C PREMENSTRUAL SYNDROME CHOLECYSTITIS CHRONIC 1
C PREMENSTRUAL SYNDROME GALLBLADDER DISORDER 1
C PREMENSTRUAL SYNDROME SCAR 1
C PRODUCT USED FOR UNKNOWN INDICATION BILIARY TRACT INFECTION 7
C PRODUCT USED FOR UNKNOWN INDICATION DECREASED APPETITE 7
C PRODUCT USED FOR UNKNOWN INDICATION DISEASE PROGRESSION 7
C PRODUCT USED FOR UNKNOWN INDICATION FATIGUE 7
C PRODUCT USED FOR UNKNOWN INDICATION HYPERSENSITIVITY 5
C PRODUCT USED FOR UNKNOWN INDICATION INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 5
C PRODUCT USED FOR UNKNOWN INDICATION WHITE BLOOD CELL COUNT DECREASED 7
C PROSTATE CANCER UVEITIS 3
C SLEEP DISORDER UVEITIS 3
C URINARY TRACT INFECTION HYPERSENSITIVITY 1
C URINARY TRACT INFECTION INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 1
C VERTIGO UVEITIS 3
Ads by Google